Clinical Trials for Corvus Pharmaceuticals

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Corvus Pharmaceuticals

Clinical Trials (3)

NCT06561048
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
PHASE3Recruiting
150 participants
Started: Oct 2, 2024 · Completed: Jul 31, 2028
7 conditions1 sponsor1 location
NCT06345404
Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe AD
PHASE1Recruiting
72 participants
Started: Apr 23, 2024 · Completed: Nov 30, 2025
1 condition1 sponsor16 locations
NCT03952078
A Dose Escalation Study Evaluating CPI-818 in Relapsed/Refractory T-Cell Lymphoma
PHASE1Active, not recruiting
151 participants
Started: May 3, 2019 · Completed: Apr 30, 2026
1 condition1 sponsor22 locations